Dear Editor, Fulminant type 1 diabetes (FT1DM) is classified as a subtype of the nonautoimmune type 1 diabetes, characterized by its clinical features of abrupt onset with ketosis or ketoacidosis and virtually no C-peptide secretion [1, 2] . FT1DM development during pregnancy may result in severe complications for both mother and fetus. To date, most of the patients with FT1DM during pregnancy have been reported in Japan [2] ; a few cases have been reported in Korea, Malaysia, France, Taiwan [3] , and mainland China [4] . Here, we report two cases of FT1DM during pregnancy seen in our hospital, which presented fetal demise.
The first woman, aged 23 years, presented with nausea and vomiting for 1 day without hyperglycemic symptoms at 32 weeks' gestation. The second case was a 21-year-old woman at 25 weeks' gestation, who had excessive thirst, polyuria, and fever for 3 days. The two patients consulted our hospital on feeling reduced fetal movements. Based on the blood and urinary examinations ( Table 1) , both of them were diagnosed with diabetic ketoacidosis (DKA), caused by FT1DM. The two patients were treated with intravenous insulin injections and a large volume of intravenous normal saline administration for DKA. Antibiotics were used to control the upper respiratory tract infection in the second case. Metabolic acidosis was controlled within 3 days. Multiple insulin injections were administered for blood glucose control. Although the two patients were treated successfully, fetal demise occurred in both cases. Both of them were followed up in the outpatient department with multiple insulin injections.
A previous nationwide survey in Japan reported that almost all female patients who developed type 1 diabetes during pregnancy appeared to have FT1DM [2] . A nationwide investigation in China also suggested that the onset of this disease was associated with pregnancy in some patients. The clinical and laboratory findings of the two cases reported here were in accord with the diagnostic criteria of FT1DM [1] . Several cases were also reported previously in countries other than Japan. These reports suggest that this disease is not a clinical entity specific to Japanese women, but can occur in pregnant women in other countries too.
FT1DM developed during pregnancy may result in severe complications for both mother and fetus due to the sudden onset and severity of maternal DKA [5] . Fetal mortality was reported to be as high as 67% [5] . In these two cases, although the two pregnant women were treated successfully, fetal demise occurred. Previous studies suggest that some characteristic symptoms, such as thirst, commoncold-like symptoms, and abdominal symptoms, may precede the onset of FT1DM [2] . Patients who developed FT1DM during pregnancy shared similar characteristics, such as high a frequency of common-cold-like symptoms and hyperglycemic symptoms [5] . The two patients reported here also presented with hyperglycemic or abdominal symptoms. However, both of them consulted our hospital on feeling reduced fetal movements. Therefore, all physicians as well as obstetricians should pay attention and not overlook the presence of ketoacidosis caused by this type of diabetes if a pregnant woman abruptly exhibits hyperglycemic, common-cold-like, or abdominal symptoms. The treatment for DKA should be carried out immediately after its development. Awareness of all medical practitioners and patients about this disease can lead to prompt diagnosis and emergency treatment and, consequently, improved maternal and fetal prognosis. WBC Z white blood cell count; RBC Z red blood cell count; Hb Z hemoglobin; Plt Z platelets; PH Z potential of hydrogen; BE Z base excess; Glu Z glucose; HbA1c Z hemoglobin A1c; TP Z total protein; Alb Z albumin; T-bil Z total bilirubin; ALT Z alanine aminotransferase; AST Z aspartate aminotransferase; ALP Z alkaline phosphatase; BUN Z blood urea nitrogen; Cr Z creatinine; T-cho Z total cholesterol; TG Z total triglycerides.
